A circulating form of NADH oxidase activity responsive to the antitumor sulfonylurea N-4(methylphenylsulfonyl)-N'-(4-chlorophenyl)urea (LY181984) specific to sera from cancer patients

Journal of Bioenergetics and Biomembranes

Volumn 29, Issue 3, 1997, Pages 281-289

  Morré, D James ^a   Reust, Timothy ^a  

^a PURDUE UNIVERSITY   (United States)

Author keywords

Antitumor drug; Cancer; Diarylsulfonylurea; NADH oxiduse; Serum; Sulfonylurea

Indexed keywords

1 (4 CHLOROPHENYL) 3 (4 METHYLPHENYLSULFONYL)UREA; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE; TUMOR MARKER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CELL MEMBRANE; CELL SURFACE; COLON CANCER; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; LEUKEMIA; LIVER CELL CARCINOMA; LYMPHOMA; MALE; NONHUMAN; RAT; SERUM;

ANIMALS; ANTINEOPLASTIC AGENTS; CULTURE MEDIA, CONDITIONED; DIMETHYL SULFOXIDE; DOSE-RESPONSE RELATIONSHIP, DRUG; HELA CELLS; HUMANS; MALE; MULTIENZYME COMPLEXES; NADH, NADPH OXIDOREDUCTASES; NEOPLASMS; RATS; RATS, INBRED F344; SULFONYLUREA COMPOUNDS;

ANIMALIA;

EID: 0030854118     PISSN: 0145479X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1022466212083     Document Type: Article

References (23)

1. Bernacki, R. J. and Kim, U. (1977). Science 195, 577-580.
2. Fuyamada, H., Hino, M., Nagatsu, T., Ogawa, K., and Sakakibara, S. (1977). Clin. Chimi. Acta 74, 177-181.
3. Grindey, G. B. (1988). Proc. Am. Assoc. Cancer Res. 29, 535-536.
4. Hanski, C., Zimmer, T., Gossrau, R., and Reutter, W. (1986). Experientia 42, 826-828.
5. Houghton, P. J., Bailey, F. C., Houghton, J. A., Murti, K. G., Howbert, J. J., and Grindey, G. B. (1980). Cancer Res. 50, 664-668.
6. Howbert, J. J. Grossman, C. S., Crowell, T. A., Rieder, B. J. Harper, R. W., Kramer, K. E., Tao, E. V. Aikins, J., Poore, G. A., Rinzel, S. M., Grindey, G. B. Shaw, W. N., and Todd, G. C. (1990). J. Med. Chem. 33, 2393-2407.
7. Ip, C. (1978). Biochim. Biophys. Acta 583, 14-19.
8. Ip, C., and Dao, T. L. (1978). Cancer Res. 38, 723-728.
9. Kloppel, T. M., and Morré, D. J. (1980). J. Natl. Cancer Inst. 64, 1401-1411.
10. Kuma, F. S., Ishizawa, K., Hiriyama, K., and Nakajima, H. (1972). J. Biol. Chem. 247, 550-555.
11. Morré, D. J., (1995). Biochim, Biophys. Acta 1240, 201-208.
12. Morré, D. J., and Morré, D. M. (1995). J. Bionerg. Biomembr. 27, 137-144.
13. Morré, D. J., Morré, D. M., Stevenson, J., MacKellar, W., and McClure, D. (1995a). Biochim. Biophys. Acta 1244, 133-140.
14. Morré, D. J. Wilkinson, F. E. Lawrence, J., Cho, N., and Paulik, M. (1995b). Biochim. Biophys. Acta 1236, 237-243.
15. Morré D. J., Wu, L.-Y., and Morré, D. M. (1995c). Biochim. Biophys. Acta 1240, 11-17.
16. Morré, D. J., Wilkinson, F. E., Kim, C., Cho, N., Lawrence, J., Morré, D. M., and McClure, D. (1996). Biochim. Biophys. Acta 1280, 197-206.
17. Nishiwaki, S., Taki, T., Handa, N., Hattori, N., Takeshita, K., Endo, M., and Handa, S. (1992). Cancer Res. 52, 1875-1880.
18. Podolsky, D. K., and Weiser, M. M. (1979). J. Biol. Chem. 254, 3983-3990.
19. Rush, G. F. Rinzel, S., Boder, G., Heim, R. A., Toth, J. E., and Ponsler, G. D. (1992). Biochem. Pharmacol. 44, 2387-2394.
20. Schultz, R. M., Anida, S. L., Boder, G. B., Toth, J. E., and Grindey, G. M. (1992). Proc. Am. Assoc. Cancer Res. 33, 488.
21. Sosinski, J., Thakar, J. H., Germain, G. S., Harwood, F. C., and Houghton, P. J. (1993). Biochem. Pharmacol. 45, 2135-2142.
22. Sun, E., Lawrence, J., Morré, D. M., Sun, I., Crane, F. L., MacKellar, W. C., and Morré, D. J. (1995). Biochem. Pharmacol. 50, 1461-1468.
23. Taylor, C. W., Alberts, D. S., Ketcham, M. A., Satterlee, W. G., Holdsworth, M. T., Pleijia, P. M., Pang, Y.-M., McCloskey, T. M., Roe, D. J., Hamilton, M., and Salmon, S. E. (1989). J. Clin. Oncol. 7, 1733-1740.